Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL753503 | 0.91 | KDM4E (0.30) | KDM4EMEN1GLAKMT2AALDH1A1 | |
| SCHEMBL12841529 | 0.82 | KIF11 (0.35) | TDP1KDM4EMEN1GAAMAPT | |
| SCHEMBL12873459 | 0.79 | ACHE (0.34) | — | |
| SCHEMBL10072420 | 0.79 | CYP1A2 (0.39) | KDM4EMEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL13540497 | 0.77 | — | — | |
| SCHEMBL13615802 | 0.76 | — | — | |
| SCHEMBL14146663 | 0.74 | EPAS1 (0.32) | TDP1ALDH1A1 | |
| SCHEMBL17951775 | 0.74 | CFTR (0.42) | KDM4EGAAKMT2AALDH1A1CYP2A6 | |
| SCHEMBL1102437 | 0.73 | GABRA1 (0.34) | KMT2AALDH1A1TSHR | |
| SCHEMBL20078693 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4503196-A | SELECTIVE, CONJUGATED DIENE COPOLYMER, RHODIUM COMPLEX CATALYST | POLYSAR LIMITED (CA) | 1985-03-05 | — | — | US | claimed |
| US-4464515-A | DIENE COPOLYMER; RHODIUM HYDRIDE/LIGAND COMPOUND CATALYST, SOLVENT | POLYSAR LIMITED (CA) | 1984-08-07 | — | — | US | claimed |
| EP-0111412-A1 | Polymer hydrogenation process | POLYSAR LIMITED (CA) | 1984-06-20 | — | — | EP | claimed |
| EP-3583211-B1 | METHOD FOR THE SYNTHESIS OF DNA CONJUGATES BY MICELLAR CATALYSIS | UNIV DORTMUND TECH (DE) | 2024-04-10 | — | — | EP | disclosed |
| CN-117777199-A | Acyl phosphine oxide compound based on phosphafluorene structure and preparation method thereof | 北京大学 | 2024-03-29 | — | — | CN | disclosed |
| US-20230236502-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE | FUJIFILM CORPORATION (JP) | 2023-07-27 | — | — | US | disclosed |
| CN-115477674-A | Organophosphorus compounds based on phosphafluorene structural units and preparation method thereof | 北京大学 | 2022-12-16 | — | — | CN | disclosed |
| CN-115477673-A | Diphosphine compound based on phosphafluorene structural unit and preparation method thereof | 北京大学 | 2022-12-16 | — | — | CN | disclosed |
| CN-115477675-A | Phosphofluorene metal salt compound and preparation method thereof | 北京大学 | 2022-12-16 | — | — | CN | disclosed |
| EP-3612544-B1 | AZITHROMYCIN DERIVATIVES CONTAINING A PHOSPHONIUM ION AS ANTICANCER AGENTS | RISING TIDE FOUND (CH) | 2022-11-23 | — | — | EP | disclosed |
| US-11427606-B2 | Azithromycin derivatives containing a phosphonium ion as anticancer agents | RISING TIDE FOUND (CH) | 2022-08-30 | — | — | US | disclosed |
| EP-0052929-A1 | Sulfonated group VA ylides and process for preparing same | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1982-06-02 | — | — | EP | disclosed |
| EP-0052930-A1 | Novel group VA salts and process for preparing same | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1982-06-02 | — | — | EP | disclosed |
| EP-0046628-A2 | Process for the preparation of nickel ylides containing directly sulfonated ylide ligands | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1982-03-03 | — | — | EP | disclosed |
| EP-0046331-A2 | Nickel ylides | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1982-02-24 | — | — | EP | disclosed |
| EP-0046332-A2 | Process for the preparation of nickel ylides containing ylide ligands with a sulfonated group V component | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1982-02-24 | — | — | EP | disclosed |
| US-4310716-A | NICKEL YLIDE CATALYST | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1982-01-12 | — | — | US | disclosed |
| US-4301318-A | OBTAINED BY REACTING ETHYLENE USING A NICKEL YLIDE CATALYST; SOLVENT EXTRACTION OF CATALYST USING AMMONIUM HYDROXIDE | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1981-11-17 | — | — | US | disclosed |
| US-4293727-A | CATALYSIS WITH NICKEL YLIDE | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1981-10-06 | — | — | US | disclosed |
| US-4293502-A | CATALYST FOR OLIGOMERIZATION OF ETHYLENE | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1981-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11427606-B2 | Azithromycin derivatives containing a phosphonium ion as anticancer agents | PHPT1, NUP205, PIK3CA | TDP1 2701/4885KDM4E 2831/4885MEN1 908/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.